SCHEMBL6520445

SCHEMBL6520445

CCCOc1ccc2c(c1)cc(C(=O)OCC)n2C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.45
MAOA P21397 1/20 0.44
NOD2 Q9HC29 1/20 0.42
NOD1 Q9Y239 1/20 0.42
GABRA1 P14867 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6514090 0.96 MAOA (0.47) NR1H2MAOANOD2NOD1GABRA1
SCHEMBL6512126 0.92 NOD2 (0.44) NR1H2MAOANOD2NOD1HPGD
SCHEMBL4821364 0.92 NR1H2 (0.44) NR1H2MAOANOD2NOD1GABRA1
SCHEMBL3027681 0.90 NR1H2 (0.42) NR1H2MAOANOD2NOD1HPGD
SCHEMBL3023791 0.89 MAOA (0.43) NR1H2MAOANOD2NOD1HPGD
SCHEMBL3027473 0.87 NR1H2 (0.41) NR1H2MAOANOD2NOD1GABRA1
SCHEMBL3035408 0.85 SRD5A2 (0.54) NR1H2MAOANOD2NOD1GABRA1
SCHEMBL12042732 0.84 NOD2 (0.52) NR1H2NOD2NOD1HPGDL3MBTL1
SCHEMBL13174688 0.83 NR1H2 (0.44) NR1H2MAOANOD2NOD1GABRA1
SCHEMBL3030334 0.83 NOD2 (0.46) NR1H2MAOANOD2NOD1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026987-A1 CBI analogues of the duocarmycins and CC-1065 THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026987-A1 CBI analogues of the duocarmycins and CC-1065 CCNI, SP1, DCK NR1H2 4276/4885MAOA 4133/4885NOD2 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.